On Sep 23, the 8th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2017) held in Torino, Italy, successfully ended after a dense 3-day agenda blending a superb scientific and educational program, with over 150 participants in the field from more than 20 countries or regions. During the meeting, we were honored to conduct an interview with Dr. Andreas Rimner from Memorial Sloan-Kettering Cancer Center to share his experiences in application of radiotherapy and treatment of lung cancer.
